|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities | |
| Net income | |
| Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities: | |
| Depreciation and amortization | |
| Amortization of debt issuance costs | |
| Provision for credit losses | |
| Stock-based compensation | |
| Deferred income tax | |
| Changes in assets and liabilities: | |
| Other assets | |
| Accounts receivable | |
| Accounts payable and accrued expenses | |
| Net cash provided by operating activities | |
| Cash flows from investing activities | |
| Purchases of receivables, net | |
| Investments in receivables, net | |
| Credit card receivables | |
| Collections applied to receivables | |
| Investments in receivables, net | |
| Credit card receivables | |
| Acquisition, net of cash acquired | |
| Purchases of property and equipment, net | |
| Net cash used in investing activities | |
| Cash flow from financing activities | |
| Proceeds from notes payable | |
| Payments on notes payable | |
| Payment of debt issuance costs | |
| Dividends paid to stockholders | |
| Proceeds from issuance of common stock | |
| Net cash (used in) / provided by financing activities | |
| Exchange rate effects on cash balances held in foreign currencies | |
| Net (decrease) increase in cash and cash equivalents and restricted cash | |
| Cash and cash equivalents and restricted cash, beginning of period | |
| Cash and cash equivalents and restricted cash, end of period | |
| Supplemental cash flow disclosures | |
| Interest paid | |
| Income taxes paid | |
| New leases assumed | |
| Deferred tax liability recognized in connection with reorganization |
Loading...
